F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy The New York Times President Trump announced that Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for weight management indications for people with obesity. Our senior staff writer Kristen Monaco Real Results. Real Confidence. Swipe to see this amazing transformation with tirzepatide injections, a powerful tool in medical weight management. Our patient achieved sustainable weight loss under physician guided care and What is the evidence for using low dose naltrexone (Naltrexone) for treating insomnia in patients who have not responded to traditional therapies? What Is Compounded Tirzepatide? How to Get Tirzepatide My Luminescence